SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously ...

Vincerx Pharma (NASDAQ:VINC) just reported results for the fourth quarter of 2023. Vincerx Pharma reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -37 cents.

In a turbulent market environment, Vincerx Pharma, Inc. (VINC) stock has reached its 52-week low, trading at $1.3. According to InvestingPro analysis, the company maintains a healthy current ratio ...

US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff Talks: 'March, April, May Tend To Be Solid Months In Post-Election Years,' Says Expert US. stock futures rose on Monday ...

Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Oil & Gas, Technology and Basic Materials ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

High-flying Kenyan rapper Khaligraph Jones has unveiled Khali Cartel 5 rap challenge. The development comes in the backdrop ...

Vincerx Pharma (VINC) announced that the previously signed binding Term Sheet between Vincerx, Oqory, and Vivasor for a reverse merger ...